Date-wise news. Poonam Pandey, who hails from Pithoragarh in Uttarakhand, has been covering the BJP, the Rashtriya Swayamsevak Sangh (RSS) and national politics Mehta was earlier with FSS as Global Marketing Director Abdullah shared a series of photographs with Nidhi on X, accompanied by the caption, 'A new journey began yesterday' Girdhar joins Publicis from Times Internet The warrant application has been filed by Arunachal Pradesh Police in connection with the violence that erupted in Pasighat on October 23 In a post on X, Sudhir Mishra revealed that his last weekly column in the Navbharat Times was published today Before joining Pernod Ricard, Atole was with Hindustan Coca-Cola Beverages as Quality Assurance Manager Agarwal talks about bridging the gap between a free click and a paid ticket Pasupathy was earlier Executive Vice President- Strategy and International Projects at Epsilon Advanced Materials The requirement has been posted by CEO Ashley in a LinkedIn post. The mandate is to Identify potential sponsors, build partnership propositions and drive sponsorship closures across multiple tiers Kumar joins Reliance Jewels from Bhima Jewels where he was the Chief Operating Officer The company wants the creative team to produce a 2-minute video showcasing its digital classroom initiative at a school in Mumbai Okamoto joins OpenAI from Stripe, where he was Head of Marketing-Japan. He was earlier Senior Manager-Marketing at Seisiun Analytics. The agency brings together expertise spanning print, television, radio and events with a digital-first approach He was earlier the Chief Operating Officer-Hospitality at Nimba Nature Cure and Holistic Healthcare Centre Rajan joins Reveleer Global Capability Center from ValGenesis, where she was Human Resources Director The appointments will also require the approval of the company's shareholders Swami Mehra has resigned to pursue new opportunities outside the company Seth was earlier the Regional Sales Head -North India, South India & Sri Lanka. As the actress celebrates her birthday tomorrow, e4m revisits Aishwarya Rai Bachchan's remarkable three-decade journey from a familiar face in 1990s advertising to a global luxury brand ambassador From Zomato's Diwali hamper to Tesla's Halloween Mode, ten campaigns this week blended festive warmth, family stories and a dash of absurd humour Previously, she was associated with Abbott India Limited In a message on X, he asked people what are the problems they face every day, for which they expect solutions from the system The BJP leader began his career as a journalist and reported on the 1971 Indo-Pak war before founding security services company SIS

Reveleer, an AI-enabled value-based care technology company, has appointed Jean-Luc Neptune, MD, MBA, as chief medical officer. He will lead clinical strategy across risk adjustment, quality, and member management programmes serving 12 million covered lives. Neptune has spent more than 20 years bringing new technology to clinicians, first as a physician and later as a digital health founder. He most recently served as clinical commercial leader at Commure. Reveleer says it has processed more than 2 billion pages of medical records. Its EVE™ AI links each suggestion to the exact page of evidence, so coders and clinicians can verify it. Neptune and chief executive officer Jay Ackerman will host a live fireside chat on November 10, 2026.

Reveleer names digital health innovator Dr. Jean-Luc Neptune Chief Medical Officer. Dr. Neptune will lead clinical strategy for Reveleer across risk adjustment, quality, and member management programs serving 12 million covered lives GLENDALE, Calif., Oct. 15, 2026 /PRNewswire/ - Reveleer, an AI-enabled value-based care technology company for health plans and provider organizations, today announced the appointment of Jean-Luc ("JL") Neptune, MD, MBA, as Chief Medical Officer. Dr. Neptune will help set clinical direction for Reveleer products and bring a seasoned clinical voice to the company's strategy across AI, value-based care, and health care payment reform. Dr. Neptune has spent more than 20 years bringing new technology to clinicians at the point of care, first as a physician and later as a digital health founder. His experience in both roles will guide how Reveleer designs AI for clinical use. His appointment comes as AI becomes integral to how patients are evaluated and treated. As evidenced by the Reveleer 2026 State of Technology in Value-Based Care report, AI adoption has outpaced operational readiness. Health plans now need AI that is fast enough to scale and transparent enough to trust. Reveleer has processed more than 2 billion pages of medical records for risk adjustment and quality programs. Because EVE(TM) AI links each suggestion to the exact page in the medical record where the evidence appears, coders and clinicians can verify it before making the final call. "Clinical judgement has to shape our AI long before any suggestion reaches a reviewer," said Jay Ackerman, CEO of Reveleer. "As risk adjustment and quality work move from chart review after the visit to the point of care, our AI puts a suggestion in front of a physician while the patient is still in the room. We know what our customers need, and JL's years practicing medicine and building health care companies make him essential to how we serve them." Reveleer Prospective Risk Adjustment does so today, delivering suspect conditions and open care gaps to clinicians in the electronic health record (EHR) before, during, and after the visit. "I've spent my career on both sides of the chart, as the physician writing the note and as the founder building software around it," said Dr. Neptune. "Clinicians trust AI when it shows its work, and every suggestion should lead straight to the evidence a physician would look for. The industry has adopted AI. Now every health plan and provider must decide which decisions belong to a clinician. At Reveleer, clinicians help answer that question as each product is planned, built, and tested. I joined to lead that work." Before joining Reveleer, Dr. Neptune served as Clinical Commercial Leader at Commure, where he helped bring care automation and AI to clinicians and health systems. Throughout his career, he has founded startups, invested in dozens of companies, practiced as a direct care physician, and operated a physical clinic. He completed his medical training at Columbia University/NewYork-Presbyterian, is board-certified in internal medicine, and earned an MBA from the Wharton School. Dr. Neptune and Ackerman will continue the conversation in a live fireside chat, Keeping Clinical Judgment at the Center of AI in Value-Based Care, on Nov. 10, 2026. The 45-minute session covers Dr. Neptune's path from clinical medicine into health care operations and investing, the conditions AI needs to work inside a clinical workflow, and the decisions that call for clinician or coder review. The session closes with audience questions. About Reveleer Reveleer delivers a unified platform spanning risk adjustment, quality improvement, clinical intelligence, and member management for health plans and provider organizations navigating the complexity of value-based care. Trusted by more than 80 customer organizations nationwide, the platform integrates data, analytics, and intelligent workflow automation into one governed system designed to support traceable documentation across diagnoses, quality measures, and submissions. With regulatory expertise and transparent, human-in-the-loop AI at its core, Reveleer supports organizations working to advance care quality, strengthen documentation integrity, and sustain the operational readiness needed to navigate audits with confidence. Media contact SOURCE Reveleer